Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram-negative bacterial infections.
Fornari C, Arrieta A, Bradley JS, Tout M, Magalhaes P, Auriol FK, Borella E, Piana C, Della Pasqua O, Vallespir BP, Mazzei P, Bokesch PM, Hoover R, Capriati A, Habboubi N.
Fornari C, et al. Among authors: della pasqua o.
Br J Clin Pharmacol. 2024 Oct;90(10):2597-2610. doi: 10.1111/bcp.16145. Epub 2024 Jun 26.
Br J Clin Pharmacol. 2024.
PMID: 38925918